UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:BCAS3-PRKAA2 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: BCAS3-PRKAA2 | FusionPDB ID: 9226 | FusionGDB2.0 ID: 9226 | Hgene | Tgene | Gene symbol | BCAS3 | PRKAA2 | Gene ID | 54828 | 5563 |
Gene name | BCAS3 microtubule associated cell migration factor | protein kinase AMP-activated catalytic subunit alpha 2 | |
Synonyms | GAOB1|MAAB | AMPK|AMPK2|AMPKa2|PRKAA | |
Cytomap | 17q23.2 | 1p32.2 | |
Type of gene | protein-coding | protein-coding | |
Description | breast carcinoma-amplified sequence 3BCAS4/BCAS3 fusionRudhirabreast carcinoma amplified sequence 4/3 fusion proteinmetastasis associated antigen of breast cancerprotein Maab1 | 5'-AMP-activated protein kinase catalytic subunit alpha-25'-AMP-activated protein kinase, catalytic alpha-2 chainACACA kinaseAMP-activated protein kinase alpha-2 subunit variant 2AMP-activated protein kinase alpha-2 subunit variant 3AMPK alpha 2AMPK | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | Q9H6U6 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000390652, ENST00000407086, ENST00000408905, ENST00000588462, ENST00000589222, ENST00000585744, ENST00000585812, ENST00000588874, | ENST00000371244, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 53 X 35 X 17=31535 | 2 X 3 X 2=12 |
# samples | 61 | 2 | |
** MAII score | log2(61/31535*10)=-5.69200088030826 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/12*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: BCAS3 [Title/Abstract] AND PRKAA2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | BCAS3(58885437)-PRKAA2(57157067), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | BCAS3-PRKAA2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Tgene partner, which is a epigenetic factor due to the frame-shifted ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. BCAS3-PRKAA2 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | BCAS3 | GO:0043085 | positive regulation of catalytic activity | 17505058 |
Hgene | BCAS3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 17505058 |
Hgene | BCAS3 | GO:0071391 | cellular response to estrogen stimulus | 17505058 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-A8-A09G-01A | BCAS3 | chr17 | 58885437 | - | PRKAA2 | chr1 | 57140054 | + |
ChimerDB4 | BRCA | TCGA-A8-A09G-01A | BCAS3 | chr17 | 58885437 | + | PRKAA2 | chr1 | 57157067 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000589222 | BCAS3 | chr17 | 58885437 | + | ENST00000371244 | PRKAA2 | chr1 | 57157067 | + | 9589 | 544 | 68 | 1966 | 632 |
ENST00000407086 | BCAS3 | chr17 | 58885437 | + | ENST00000371244 | PRKAA2 | chr1 | 57157067 | + | 9569 | 524 | 48 | 1946 | 632 |
ENST00000390652 | BCAS3 | chr17 | 58885437 | + | ENST00000371244 | PRKAA2 | chr1 | 57157067 | + | 9552 | 507 | 31 | 1929 | 632 |
ENST00000408905 | BCAS3 | chr17 | 58885437 | + | ENST00000371244 | PRKAA2 | chr1 | 57157067 | + | 9521 | 476 | 0 | 1898 | 632 |
ENST00000588462 | BCAS3 | chr17 | 58885437 | + | ENST00000371244 | PRKAA2 | chr1 | 57157067 | + | 9521 | 476 | 0 | 1898 | 632 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000589222 | ENST00000371244 | BCAS3 | chr17 | 58885437 | + | PRKAA2 | chr1 | 57157067 | + | 7.96E-05 | 0.99992037 |
ENST00000407086 | ENST00000371244 | BCAS3 | chr17 | 58885437 | + | PRKAA2 | chr1 | 57157067 | + | 7.92E-05 | 0.99992085 |
ENST00000390652 | ENST00000371244 | BCAS3 | chr17 | 58885437 | + | PRKAA2 | chr1 | 57157067 | + | 7.86E-05 | 0.99992144 |
ENST00000408905 | ENST00000371244 | BCAS3 | chr17 | 58885437 | + | PRKAA2 | chr1 | 57157067 | + | 7.83E-05 | 0.9999217 |
ENST00000588462 | ENST00000371244 | BCAS3 | chr17 | 58885437 | + | PRKAA2 | chr1 | 57157067 | + | 7.83E-05 | 0.9999217 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >9226_9226_1_BCAS3-PRKAA2_BCAS3_chr17_58885437_ENST00000390652_PRKAA2_chr1_57157067_ENST00000371244_length(amino acids)=632AA_BP=159 MNEAMATDSPRRPSRCTGGVVVRPQAVTEQSYMESVVTFLQDVVPQAYSGTPLTEEKEKIVWVRFENADLNDTSRNLEFHEIHSTGNEPP LLIMIGYSDGMQVWSIPISGEAQELFSVRHGPIRAARILPAPQFGAQKCDNFAEKRPLLGVCKSIGSSGYQVISTPTDFFMVMEYVSGGE LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPED PSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMHIPPGLKPHPERM PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLV DNRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRPRSSFDSTTAESHSLSGSLTGSLTGSTLSSVSPRLGSHTMDFFEMCASLITTL -------------------------------------------------------------- >9226_9226_2_BCAS3-PRKAA2_BCAS3_chr17_58885437_ENST00000407086_PRKAA2_chr1_57157067_ENST00000371244_length(amino acids)=632AA_BP=159 MNEAMATDSPRRPSRCTGGVVVRPQAVTEQSYMESVVTFLQDVVPQAYSGTPLTEEKEKIVWVRFENADLNDTSRNLEFHEIHSTGNEPP LLIMIGYSDGMQVWSIPISGEAQELFSVRHGPIRAARILPAPQFGAQKCDNFAEKRPLLGVCKSIGSSGYQVISTPTDFFMVMEYVSGGE LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPED PSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMHIPPGLKPHPERM PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLV DNRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRPRSSFDSTTAESHSLSGSLTGSLTGSTLSSVSPRLGSHTMDFFEMCASLITTL -------------------------------------------------------------- >9226_9226_3_BCAS3-PRKAA2_BCAS3_chr17_58885437_ENST00000408905_PRKAA2_chr1_57157067_ENST00000371244_length(amino acids)=632AA_BP=159 MNEAMATDSPRRPSRCTGGVVVRPQAVTEQSYMESVVTFLQDVVPQAYSGTPLTEEKEKIVWVRFENADLNDTSRNLEFHEIHSTGNEPP LLIMIGYSDGMQVWSIPISGEAQELFSVRHGPIRAARILPAPQFGAQKCDNFAEKRPLLGVCKSIGSSGYQVISTPTDFFMVMEYVSGGE LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPED PSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMHIPPGLKPHPERM PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLV DNRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRPRSSFDSTTAESHSLSGSLTGSLTGSTLSSVSPRLGSHTMDFFEMCASLITTL -------------------------------------------------------------- >9226_9226_4_BCAS3-PRKAA2_BCAS3_chr17_58885437_ENST00000588462_PRKAA2_chr1_57157067_ENST00000371244_length(amino acids)=632AA_BP=159 MNEAMATDSPRRPSRCTGGVVVRPQAVTEQSYMESVVTFLQDVVPQAYSGTPLTEEKEKIVWVRFENADLNDTSRNLEFHEIHSTGNEPP LLIMIGYSDGMQVWSIPISGEAQELFSVRHGPIRAARILPAPQFGAQKCDNFAEKRPLLGVCKSIGSSGYQVISTPTDFFMVMEYVSGGE LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPED PSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMHIPPGLKPHPERM PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLV DNRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRPRSSFDSTTAESHSLSGSLTGSLTGSTLSSVSPRLGSHTMDFFEMCASLITTL -------------------------------------------------------------- >9226_9226_5_BCAS3-PRKAA2_BCAS3_chr17_58885437_ENST00000589222_PRKAA2_chr1_57157067_ENST00000371244_length(amino acids)=632AA_BP=159 MNEAMATDSPRRPSRCTGGVVVRPQAVTEQSYMESVVTFLQDVVPQAYSGTPLTEEKEKIVWVRFENADLNDTSRNLEFHEIHSTGNEPP LLIMIGYSDGMQVWSIPISGEAQELFSVRHGPIRAARILPAPQFGAQKCDNFAEKRPLLGVCKSIGSSGYQVISTPTDFFMVMEYVSGGE LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPED PSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMHIPPGLKPHPERM PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLV DNRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRPRSSFDSTTAESHSLSGSLTGSLTGSTLSSVSPRLGSHTMDFFEMCASLITTL -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:58885437/chr1:57157067) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
BCAS3 | . |
FUNCTION: Plays a role in angiogenesis. Participates in the regulation of cell polarity and directional endothelial cell migration by mediating both the activation and recruitment of CDC42 and the reorganization of the actin cytoskeleton at the cell leading edge. Promotes filipodia formation (By similarity). Functions synergistically with PELP1 as a transcriptional coactivator of estrogen receptor-responsive genes. Stimulates histone acetyltransferase activity. Binds to chromatin. {ECO:0000250|UniProtKB:Q8CCN5, ECO:0000269|PubMed:17505058}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | PRKAA2 | chr17:58885437 | chr1:57157067 | ENST00000371244 | 1 | 9 | 291_376 | 78.66666666666667 | 553.0 | Region | AIS |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | PRKAA2 | chr17:58885437 | chr1:57157067 | ENST00000371244 | 1 | 9 | 16_268 | 78.66666666666667 | 553.0 | Domain | Protein kinase | |
Tgene | PRKAA2 | chr17:58885437 | chr1:57157067 | ENST00000371244 | 1 | 9 | 22_30 | 78.66666666666667 | 553.0 | Nucleotide binding | ATP |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
BCAS3 | |
PRKAA2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to BCAS3-PRKAA2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to BCAS3-PRKAA2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |